Form PREN14A - Non-management preliminary proxy statements:
SEC Accession No. 0001829126-22-014317
Filing Date
2022-07-14
Accepted
2022-07-14 12:47:23
Documents
3
Period of Report
2022-07-13

Document Format Files

Seq Description Document Type Size
1 PREN14A titanpharma_pren14a.htm PREN14A 207414
2 GRAPHIC image_001.jpg GRAPHIC 6065
3 GRAPHIC image_002.jpg GRAPHIC 6065
  Complete submission text file 0001829126-22-014317.txt   225977
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREN14A | Act: 34 | File No.: 001-13341 | Film No.: 221082672
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036 646 768 8417
Activist Investing LLC (Filed by) CIK: 0001817604 (see all company filings)

EIN.: 833953038 | State of Incorp.: NY | Fiscal Year End: 1231
Type: PREN14A